Table of Contents
Common Names:
- English: Kava, Kava Kava, Awa, Yaqona, Sakau
- Dutch: Kava, Kava Kava, Ava Peper, Kavawortel
Binomial Name:
Piper methysticum
Family:
Piperaceae (Pepper family)
Used Plant Parts:
- Root (Primary part used for traditional preparations)
- Rhizome (Underground stem, often processed similarly to the root)
Kava contains 18 different kavalactones, but just six of them make up 90–95% of its active compounds, influencing its flavor, potency, and effects.
Fact 1 of 4
Origins, Distribution, and Habitat
Origin and Historical Background
Kava kava (Piper methysticum), commonly known as kava, originates from the Pacific Islands, where it has been cultivated and used for over 3,000 years. The plant is believed to have first been domesticated in Vanuatu, with its cultivation spreading across Fiji, Tonga, Samoa, Papua New Guinea, and Hawaii.
Kava holds a deep cultural and spiritual significance in Pacific Island societies. Traditionally, it was used in ceremonial rituals, social gatherings, and healing practices. Polynesian, Micronesian, and Melanesian communities considered kava a sacred plant, often consuming it in communal settings to promote relaxation, social bonding, and connection with ancestral spirits.
Geographical Distribution
Today, Piper methysticum is grown extensively throughout the South Pacific, including:
- Vanuatu – Considered the genetic birthplace of kava, producing many of the highest-quality cultivars.
- Fiji – A major exporter, where kava is an integral part of traditional and daily life.
- Tonga & Samoa – Used for both ritual and recreational consumption.
- Papua New Guinea – Grown mostly in coastal regions.
- Hawaii – Introduced by early Polynesian settlers and cultivated in traditional Hawaiian medicine (Lāʻau Lapaʻau).
Outside its native range, kava is now commercially grown in parts of:
- Australia (Northern Queensland)
- New Zealand (Limited cultivation)
- Southeast Asia (Experimental growth in Indonesia and the Philippines)
Preferred Habitat and Growing Conditions
Kava thrives in tropical and subtropical climates, particularly in coastal and lowland forest regions. Its ideal growing conditions include:
- Warm temperatures – Kava requires consistent heat between 21–32°C (70–90°F).
- High humidity – It flourishes in moist environments with frequent rainfall.
- Well-drained, nutrient-rich volcanic soils – These provide the minerals necessary for healthy root development.
- Shaded areas – The plant prefers partial sunlight, often growing under the canopy of taller trees.
Unlike wild relatives in the Piper genus, domesticated kava plants are sterile, meaning they do not produce viable seeds. Instead, they are propagated through stem cuttings, requiring human intervention for cultivation.
Ecological Role
Though primarily cultivated for human use, Piper methysticum contributes to its ecosystem by:
- Providing ground cover that prevents soil erosion in tropical climates.
- Supporting biodiversity, as its broad leaves offer shelter for insects and small wildlife.
- Acting as a natural pesticide, as certain kavalactones (bioactive compounds) deter pests.
Botanical Description:
Plant Structure and Growth Habit
Kava kava (Piper methysticum) is a perennial, shrub-like plant belonging to the Piperaceae (pepper) family. It typically grows to a height of 2–3 meters (6–10 feet), with a bushy, well-branched structure. Unlike many other members of the Piper genus, domesticated kava plants are sterile and do not produce viable seeds, meaning they can only be propagated through stem cuttings.
Stems and Branches
The woody stems of kava are thick and knotted, often displaying a light brown or reddish hue. They contain aerial nodes, which allow for easy propagation when cut and replanted. The stems also contain kavalactones (bioactive compounds), though in lower concentrations than the roots.
Leaves and Foliage
Kava’s broad, heart-shaped leaves are a distinctive feature of the plant. Their characteristics include:
- Shape: Large, ovate to cordate (heart-shaped) with a pointed tip.
- Size: Each leaf measures between 10–30 cm (4–12 inches) in length.
- Color: A deep green, sometimes with a slightly glossy surface.
- Texture: The leaves are smooth yet leathery, with a prominent central vein and well-defined secondary veins.
Kava leaves are aromatic when crushed, releasing a mild peppery scent due to the presence of essential oils.
Flowers and Reproductive Features
Unlike many other flowering plants, domesticated kava does not produce viable seeds. However, it does generate small, spike-like inflorescences (flower clusters) that rarely mature into fruit. These flowers:
- Are pale green or yellowish-white.
- Measure about 4–7 cm (1.5–3 inches) in length.
- Lack petals and instead consist of tiny, clustered reproductive structures.
Since kava is propagated vegetatively (by stem cuttings), its inability to produce seeds does not affect its cultivation.
Root System and Rhizomes
The roots and rhizomes (underground stems) of kava are its most valuable part, both agriculturally and medicinally. Key features include:
- Thick, fibrous lateral roots that extend outward, stabilizing the plant.
- Large, woody rhizomes (underground stems) that store the highest concentration of kavalactones, the plant’s primary bioactive compounds.
- Color variation from light beige to dark brown, depending on soil conditions and plant maturity.
Mature kava plants are typically harvested after 3–5 years, when their root system has fully developed and reached optimal potency.
Growth and Adaptations
As a plant native to the tropical Pacific Islands, kava is well adapted to warm, humid environments. Its adaptations include:
- Deep root structures, which help it absorb nutrients from volcanic soils.
- Shade tolerance, allowing it to grow under taller forest trees.
- Sterile reproduction, which prevents uncontrolled spreading and ensures that each new plant is a genetic copy of its parent.
Kava has been cultivated and consumed for over 3,000 years in the Pacific Islands, where it remains central to ceremonial and social gatherings.
Fact 2 of 4
Active Compounds
Kava kava is rich in bioactive compounds that contribute to its unique properties. The most notable of these are kavalactones, but the plant also contains various alkaloids, flavonoids, and essential oils that influence its aroma, taste, and biochemical profile.
Kavalactones – The Primary Active Compounds
Kavalactones are fat-soluble compounds found mainly in the roots and rhizomes (underground stems) of the plant. They are responsible for kava’s distinctive earthy taste and play a key role in the plant’s biological effects. Scientists have identified over 18 different kavalactones, but the six most abundant ones—often referred to as the “kava chemotype”—account for 90–95% of the total kavalactone content.
The Six Major Kavalactones
Each kavalactone has a different chemical structure and function within the plant:
- Kavain – Contributes to the plant’s mild numbing effect on the tongue when consumed.
- Dihydrokavain (DHK) – A structurally similar compound that influences kava’s sensory profile.
- Methysticin – A compound that affects kava’s aroma and taste, giving it a slightly peppery quality.
- Dihydromethysticin (DHM) – A closely related molecule that enhances kava’s natural defense mechanisms.
- Yangonin – Found in moderate amounts, it plays a role in the plant’s metabolic processes.
- Desmethoxyyangonin (DMY) – One of the lesser-known kavalactones, but still significant in kava’s chemical makeup.
Distribution of Kavalactones
- Kavalactones are most concentrated in the roots, making them the only part of the plant traditionally used.
- The stems and leaves contain very little kavalactone, which is why they are generally not consumed.
Flavokavains – Natural Polyphenols
Flavokavains (also called flavokavins) are polyphenols (plant-based antioxidants) found in kava, particularly in the aerial parts (stems and leaves). These compounds include:
- Flavokavain A – Involved in plant defense mechanisms, helping protect kava from fungi and pests.
- Flavokavain B – Found in higher concentrations in certain kava cultivars, influencing plant metabolism.
- Flavokavain C – Plays a role in pigmentation and environmental stress adaptation.
These flavokavains contribute to kava’s chemical diversity, but unlike kavalactones, they are not the primary compounds of interest.
Alkaloids – Nitrogen-Based Plant Compounds
Kava contains small amounts of alkaloids (naturally occurring nitrogen-containing compounds found in plants). Although present in low concentrations, they may influence the plant’s growth and ecological interactions.
Some alkaloids found in kava include:
- Piperidine alkaloids – These are also found in black pepper and play a role in the plant’s pungency.
- Harmane alkaloids – Contribute to the chemical complexity of kava, though they are not as abundant as in other plants.
Essential Oils – Aromatic Volatile Compounds
The distinct smell of fresh kava root is due to its essential oil content. These oils contain:
- Terpenes – Organic compounds that give kava its earthy, slightly peppery aroma.
- Sesquiterpenes – Found in many medicinal plants, they help protect kava from environmental stress.
The essential oils in kava play a minor role in its overall chemical composition, but they contribute to its flavor and preservation.
Starch and Fiber – Structural Components
Although not classified as active compounds, starch and dietary fiber make up a significant portion of the kava root:
- Starch (up to 43%) – Serves as the plant’s primary energy storage molecule.
- Dietary fiber – Supports the structural integrity of the root and contributes to the texture of traditional kava preparations.
Uses in Traditional Medicine
For centuries, kava kava has been an integral part of traditional medicine and cultural rituals across the Pacific Islands. Its roots were revered not only for their calming and ceremonial properties but also for their medicinal applications.
While kava’s primary use remained within the Pacific, early European explorers and Dutch traders took an interest in the plant, bringing it to European apothecaries.
Pacific Island Traditions: The Birthplace of Kava
Kava has been cultivated and used for over 3,000 years in the islands of Polynesia, Melanesia, and Micronesia, particularly in Vanuatu, Fiji, Tonga, Samoa, and Hawaii. Traditionally, it was prepared by chewing, grinding, or pounding the root into a paste and then mixing it with water to create a ceremonial drink.
Fiji
In Fijian culture, kava—locally known as “yaqona”—played a central role in community bonding and spiritual ceremonies.
- It was offered to village chiefs and visiting dignitaries as a sign of respect.
- Traditional healers used kava to relieve tension and treat minor illnesses.
- It was commonly consumed in Bose (council meetings) and during conflict resolution rituals.
Tonga
In Tonga, kava—called “kava Tonga”—was associated with nobility, storytelling, and sacred gatherings.
- The drink was prepared for kava circles (social drinking sessions), where elders passed wisdom to younger generations.
- It was believed that consuming kava before battle gave warriors clarity and courage.
- Some traditional healers applied kava pastes to wounds or skin irritations.
Hawaii
Hawaiians referred to kava as “ʻawa”, considering it a sacred plant with divine origins.
- Native healers (kahuna) used it to ease spiritual unrest and promote well-being.
- It was incorporated into religious rituals and offerings to Hawaiian gods.
- Pregnant women and elders were sometimes given mild kava preparations to aid in childbirth or aging-related discomforts.
Vanuatu: The Spiritual Heart of Kava
Vanuatu is believed to be the genetic origin of kava, where the plant has been cultivated for thousands of years.
- Kava was prepared during initiation rites, funerals, and tribal peace ceremonies.
- Chiefs and elders consumed kava to connect with ancestors and spirits.
- It was used as a traditional medicine for fevers, infections, and muscle soreness.
Kava in Early European Encounters
Exploration and Dutch Interest
When European explorers arrived in the Pacific in the 17th century, they encountered kava-drinking traditions among indigenous islanders. Dutch and Spanish sailors were among the first Europeans to document kava use.
- In 1643, Dutch explorer Abel Tasman observed kava consumption in Tonga and Fiji, describing its sedative and ritualistic effects.
- By the 18th century, Dutch and British traders introduced dried kava root to Europe, where it was studied in early herbal medicine texts.
- In Dutch apothecaries, kava was listed as an exotic botanical, though it never gained widespread use.
Kava in 18th and 19th Century Dutch Herbalism
While kava never became a mainstream medicinal herb in the Netherlands, some Dutch herbalists and colonial traders experimented with its properties.
- Kava root was occasionally sold in Dutch trading posts in Southeast Asia, where it was sometimes mixed with other spices.
- It was referenced in early Dutch botanical texts, often compared to Asian medicinal plants like betel nut and ginseng.
- Unlike in the Pacific, kava did not gain significant cultural or medicinal popularity in the Netherlands, likely due to its strong taste and lack of familiarity in European pharmacology.
Traditional Use Beyond the Pacific
Although its primary use was in Oceania, kava made small but notable appearances in other herbal traditions:
- India – Some early traders brought kava to South Asia, where it was briefly explored as a potential alternative to Ayurvedic sedatives.
- Southeast Asia – In places like Indonesia and the Philippines, small amounts of kava were introduced through Dutch and Spanish trade routes, though it never replaced local herbal remedies.
- Middle East – Some kava root shipments reached Middle Eastern spice markets, where it was classified as an “island remedy” with possible relaxing effects.
Vanuatu is the world’s largest producer and exporter of kava, contributing to an industry worth over $200 million annually.
Fact 3 of 4
Evidence-Based Medical Applications
1. Anxiety and Stress Reduction
Kava has been extensively studied for its anxiolytic (anxiety-reducing) properties. Clinical trials demonstrate that standardized kava extract (containing 50-70 mg kavalactones three times daily) significantly reduces symptoms of generalized anxiety disorder (GAD) compared to placebo (Pittler & Ernst, 2003).
The anxiolytic effects are comparable[1] to benzodiazepines but without sedative side effects (Gorringe, 1999).
Mechanism of Action:
- Kavalactones modulate GABA-A receptors, leading to muscle relaxation and reduced anxiety.
- Inhibition of norepinephrine uptake contributes to calming effects (Gorringe, 1999).
2. Sleep Disorders and Insomnia
Studies indicate that kava improves sleep quality in patients with mild insomnia. A double-blind trial found that 200 mg kava extract per night improved sleep latency and duration within four weeks (Sarris et al., 2013).
Mechanism of Action:
- Enhances GABAergic transmission, reducing excitatory signals in the brain.
- Modulates serotonin levels, promoting relaxation.
3. Pain Management
Some studies[2] suggest kava’s potential as a non-opioid analgesic. Kavalactones have demonstrated analgesic effects via sodium channel inhibition (Furgiuele et al., 1965). Kava extract has been used for muscle tension relief and headache management.
Mechanism of Action:
- Blocks sodium channels, reducing nerve pain transmission.
- Modulates cannabinoid receptors (CB1) for mild[3] pain relief (Chow et al., 2024).
4. Anticonvulsant Effects
Preclinical studies[4] suggest kava’s effectiveness in seizure disorders. Methysticin, a kavalactone, reduces seizure frequency by modulating voltage-gated ion channels (Schmitz et al., 1995).
Mechanism of Action:
- Enhances GABAergic inhibition.
- Reduces glutamate release, limiting excitotoxicity.
5. Muscle Relaxation and Tension Reduction
Kava’s muscle-relaxing effects are well-documented[5]. Athletes use it as a natural muscle relaxant post-exercise. 300-600 mg/day reduces muscle stiffness without impairing cognitive function (Selvan, 2013).
Mechanism of Action:
- Inhibits calcium channels, reducing muscle excitability.
- Modulates dopamine receptors, promoting relaxation.
Applications Requiring Further Research
1. Neuroprotection and Cognitive Enhancement
Preliminary studies[6] indicate that kava protects neurons from oxidative stress, suggesting a role in neurodegenerative disorders like Alzheimer’s and Parkinson’s (Jahan et al., 2022).
Proposed Mechanism:
- Reduces neuroinflammation by modulating cytokine pathways.
- Protects neurons via antioxidant effects.
2. Antimicrobial and Antiviral Properties
Kava extracts exhibit antimicrobial effects against Salmonella paratyphi, E. coli, and other bacteria (Tanjung & Ngili, 2016). Its antiviral potential against influenza and herpes viruses is under investigation.
Proposed Mechanism:
- Disrupts bacterial cell membranes.
- Inhibits viral replication.
3. Liver Protection and Detoxification
Although concerns about hepatotoxicity exist, some research suggests that low-dose kava may protect liver cells from oxidative damage (Schmidt et al., 2002).
Proposed Mechanism:
- Enhances glutathione synthesis, reducing oxidative stress.
- Modulates cytochrome P450 enzymes to minimize toxic byproduct accumulation.
4. Potential Role in Cancer Treatment
Certain kavalactones, particularly yangonin, exhibit cytotoxic effects against cancer cells, inhibiting[7] tumor growth in vitro (Van et al., 2018).
Proposed Mechanism:
- Induces apoptosis (programmed cell death) in tumor cells.
- Suppresses angiogenesis (new blood vessel formation in tumors).
Recommended Dosage
Dosage for Adults
The recommended therapeutic dosage of Piper methysticum primarily depends on its active compounds, kavalactones. Studies[8] suggest that an effective daily dose ranges from 50 to 250 mg of kavalactones, depending on the purpose of use (Sarris et al., 2009).
Clinical trials assessing its anxiolytic (anxiety-reducing) effects recommend an average dosage of 250 mg of kavalactones per day, divided into two or three doses (Sarris et al., 2009).
Dosage Guidelines for Specific Uses in Adults
- Generalized Anxiety Disorder (GAD): Studies[9] indicate that 120 to 250 mg of kavalactones daily significantly reduces anxiety symptoms without severe adverse effects (Sarris et al., 2023).
- Insomnia and Sleep Disorders: Lower[10] doses of 50 to 100 mg of kavalactones before bedtime improve sleep quality (Melchert et al., 2022).
- Muscle Relaxation and Pain Relief: Doses up to 200 mg of kavalactones per day provide[11] muscle relaxation and mild analgesic effects (Piscopo, 2002).
Toxicity and Safety Considerations
The maximum recommended[12] dose of kavalactones should not exceed 300 mg per day to avoid potential hepatotoxicity (Yamazaki et al., 2008). High doses (over 380 mg/kg/day in animal studies) have been linked to increased liver enzyme levels and hepatocellular damage (Yamazaki et al., 2008).
Standardized aqueous extracts show reduced hepatotoxic risks compared to ethanol or acetone-based extracts (Sarris et al., 2009).
Dosage for Children
Scientific data on kava use in children remain limited, and pediatric use is generally not recommended due to potential hepatotoxicity risks. However, some traditional uses in the Pacific Islands involve administering small doses for mild sedation.
Potential Pediatric Dosage Guidelines (Not Clinically Established)
- Mild Sedative Effects: Based on adult equivalent dosing, an estimated[13] safe range for children over 12 years old could be 50-100 mg of kavalactones per day (Sarris et al., 2009).
- Anxiety Management: If prescribed under medical supervision, a cautious starting dose of 1.5 mg/kg of body weight may be used, adjusted based on clinical response (Sarris et al., 2012).
Side Effects
1. Hepatotoxicity and Liver Damage
Kava has been linked to cases of severe liver toxicity, including hepatitis, cirrhosis, and liver failure (Robinson et al., 2009). The FDA issued a warning in 2002 due to reports of hepatotoxicity in individuals consuming kava products.
The primary toxic compounds, kavalactones, inhibit cytochrome P450 enzymes, leading[14] to reduced metabolism of hepatotoxic substances and potential liver damage (Provino, 2009). Studies in animal models confirm increased liver enzyme levels after chronic kava consumption (Yamazaki et al., 2008).
2. Neurological and Psychological Effects
Kava exhibits sedative, anxiolytic, and muscle relaxant effects due to its modulation of GABAergic activity (Sarris et al., 2023). Long-term or high-dose consumption can lead to drowsiness, dizziness, and impairment in motor coordination. Chronic use has been associated with kava dermopathy, a scaly, yellowish skin condition affecting long-term users (Robinson et al., 2009).
3. Cardiovascular Effects
High doses of kava may lower blood pressure and slow heart rate due to its effects on calcium channel modulation (Sarris et al., 2012). Some individuals experience hypotension and bradycardia after excessive consumption.
4. Gastrointestinal Disturbances
Common gastrointestinal side effects include nausea, stomach discomfort, and loss of appetite (Robinson et al., 2009). These effects may be due to the inhibition of gastrointestinal motility and enzymatic activity.
5. Hormonal Effects and Reproductive Toxicity
Some studies indicate that kava may influence hormone levels, particularly through modulation of dopamine and prolactin pathways (Sarris et al., 2023). Although data on human fertility effects remain limited, animal studies[15] show potential reproductive toxicity with chronic use (Pinto et al., 2005).
Drug Interactions
1. Sedatives and CNS Depressants
Kava potentiates the effects of benzodiazepines (e.g., Xanax, Valium), barbiturates, and alcohol by enhancing GABAergic activity, increasing[16] sedation and respiratory depression risks (Gorringe, 1999). Individuals using these medications should avoid kava.
2. Hepatotoxic Drugs
Concomitant use with hepatotoxic drugs such as acetaminophen, methotrexate, and certain antibiotics may exacerbate liver damage (Robinson et al., 2009).
3. Antidepressants and Anxiolytics
Kava may interact with SSRIs, MAOIs, and other anxiolytics, enhancing sedative effects and increasing serotonin syndrome risk (Sarris et al., 2012).
4. Antihypertensive Medications
Due to its mild hypotensive effects, kava may enhance the effects of beta-blockers, calcium channel blockers, and ACE inhibitors, leading to excessive blood pressure reduction (Sarris et al., 2012).
5. Anticoagulants and Antiplatelet Drugs
Kava may alter blood clotting mechanisms[17] and increase bleeding risk when combined with warfarin, aspirin, and other anticoagulants (Weiss et al., 2005).
Noble kava varieties (preferred for daily use) contain higher kavain levels, while wild “tudei” kava varieties have up to 4 times more dihydrokavain, making their effects last much longer.
Fact 4 of 4
Bibliography
- [1] Gorringe, R. (1999). Piper methysticum: An anxiolytic. Australian Journal of Medical Herbalism, 11, 145.
- [2] Furgiuele, A. R., Kinnard, W., Aceto, M., & Buckley, J. (1965). Central activity of aqueous extracts of Piper methysticum (kava). Journal of Pharmaceutical Sciences, 54, 247-252. https://doi.org/10.1002/JPS.2600540218
- [3] Chow, L., Lin, P.-C., Chen, Y.-J., Chen, Y.-H., & Huang, E. (2024). Yangonin, one of the kavalactones isolated from Piper methysticum, acts through cannabinoid 1 (CB1) receptors to induce an intrathecal anti-hyperalgesia. Journal of Ethnopharmacology.
- [4] Schmitz, D., Zhang, C., Chatterjee, S., & Heinemann, U. (1995). Effects of methysticin on three different models of seizure-like events studied in rat hippocampal and entorhinal cortex slices. Naunyn-Schmiedeberg’s Archives of Pharmacology, 351, 348-355. https://doi.org/10.1007/BF00169074
- [5] Selvan, A. (2013). Effect of Piper methysticum root on CNS activity. Journal of Pharmaceutical Sciences.
- [6] Jahan, N., Monira, S., Orna, S. K., & Hossain, A. (2022). Phytochemical and pharmacological evaluation of methanolic leaf extract of Piper methysticum. Bangladesh Pharmaceutical Journal, 25(1), 73-79. https://doi.org/10.3329/bpj.v25i1.57843
- [7] Van, T. M., Xuan, T., Minh, T. N., & Quan, N. V. (2018). Isolation and purification of potent growth inhibitors from Piper methysticum root. Molecules, 23, 81907. https://doi.org/10.3390/molecules23081907
- [8] Sarris, J., Kavanagh, D., Byrne, G., Bone, K., Adams, J., & Deed, G. (2009). The Kava Anxiety Depression Spectrum Study (KADSS): A randomized, placebo-controlled, cross-over trial using an aqueous extract of Piper methysticum. Planta Medica, 75, 888-889. https://doi.org/10.1055/S-0029-1234275
- [9] Sarris, J., Savage, K., Hughes, M., Bousman, C. A., Rossell, S. L., Scholey, A., Stough, C., & Suo, C. (2023). Neuroimaging Insights: Kava’s (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder. Nutrients, 15. https://doi.org/10.3390/nu15214586
- [10] Melchert, P. W., Qian, Y., Zhang, Q., Klee, B. O., Xing, C., & Markowitz, J. (2022). In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones. Chemico-Biological Interactions. https://doi.org/10.1016/j.cbi.2022.109883
- [11] Piscopo, G. (2002). Kava Kava: Gift of the Islands. Alternative Medicine Review, 2(5), 355-364.
- [12] Yamazaki, Y., Hashida, H., Arita, A., Hamaguchi, K., & Shimura, F. (2008). High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats. Food and Chemical Toxicology, 46(12), 3732-3738. https://doi.org/10.1016/j.fct.2008.09.052
- [13] Sarris, J., Kavanagh, D., Adams, J., Bone, K., & Byrne, G. (2012). Kava Anxiety Depression Spectrum Study (KADSS): A mixed methods RCT using an aqueous extract of Piper methysticum. Complementary Therapies in Medicine, 17(3), 176-178. https://doi.org/10.1016/j.ctim.2009.01.001
- [14] Provino, R. (2009). Toxicology: ‘Piper Methysticum’, Kava Kava. Australian Journal of Medical Herbalism, 21, 104-105.
- [15] Pinto, V. M., Roberto, J., & Braga de Mello (2005). Toxicological evaluation of the phytotherapic formulation containing Piper methysticum Forst, Piperacea (Kava kava®) during prenatal development in Wistar rats.
- [16] Gorringe, R. (1999). Piper methysticum: An anxiolytic. Australian Journal of Medical Herbalism, 11, 145.
- [17] Weiss, J., Sauer, A., Frank, A., & Unger, M. (2005). Extracts and kavalactones of Piper methysticum G. Forst (Kava-Kava) inhibit P-glycoprotein in vitro. Drug Metabolism and Disposition, 33, 1580 – 1583. https://doi.org/10.1124/dmd.105.005892